Project Number 3K01AG055694-05S1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Receptor-mediated clearance of synaptic tau as a novel therapy for Alzheimer's disease. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 6. Autophagy, Endocytosis and Membrane Trafficking a. Proteostasis Category F. Research Resources 3. Professional and Career Development c. Career Development Researcher and Organization Principal Investigator MYEKU, NATURA Principal Investigator First Name NATURA Principal Investigator Last Name MYEKU Awardee Organization COLUMBIA UNIVERSITY Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $122,241 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YANG, AUSTIN JYAN-YU
